Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Short-term Investments (2019 - 2025)

Historic Short-term Investments for Nutex Health (NUTX) over the last 5 years, with Q1 2025 value amounting to $2.9 million.

  • Nutex Health's Short-term Investments changed N/A to $2.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2024, which is N/A changed from last year.
  • Nutex Health's Short-term Investments amounted to $2.9 million in Q1 2025.
  • In the past 5 years, Nutex Health's Short-term Investments ranged from a high of $15.0 million in Q1 2021 and a low of $2.9 million during Q4 2024
  • For the 3-year period, Nutex Health's Short-term Investments averaged around $10.2 million, with its median value being $15.0 million (2021).
  • Over the last 5 years, Nutex Health's Short-term Investments had its largest YoY gain of 1490000.0% in 2021, and its largest YoY loss of 1490000.0% in 2021.
  • Quarter analysis of 3 years shows Nutex Health's Short-term Investments stood at $15.0 million in 2021, then tumbled by 80.39% to $2.9 million in 2024, then changed by 0.0% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q1 2025, $2.9 million for Q4 2024, and $15.0 million during Q3 2021.